The Pharmaceutical segment of Johnson & Johnson invested $4.4 billion in 2010 on research & development. The Pharmaceutical segment's broad portfolio focuses on unmet medical needs across several therapeutic areas: oncology; infectious disease; immunology; neuroscience; cardiovascular and metabolism. It includes products in the anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology fields. Below are some of our main products.
The Pharmaceutical segment of Johnson & Johnson invested $4.4 billion in 2010 on research & development. The Pharmaceutical segment's broad portfolio focuses on unmet medical needs across several therapeutic areas: oncology; infectious disease; immunology; neuroscience; cardiovascular and metabolism. It includes products in the anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology fields. Below are some of our main products.